Possible implications and applications of the yeast killer phenomenon in the fight against infectious diseases are reviewed, with particular reference to some wide-spectrum killer toxins (KTs) produced by Wickerhamomyces anomalus and other related species. A perspective on the applications of these KTs in the medical field is provided considering (1) a direct use of killer strains, in particular in the symbiotic control of arthropod-borne diseases; (2) a direct use of KTs as experimental therapeutic agents; (3) the production, through the idiotypic network, of immunological derivatives of KTs and their use as potential anti-infective therapeutics. Studies on immunological derivatives of KTs in the context of vaccine development are also described.

Wickerhamomyces yeast killer toxins’ medical applications / Giovati, L.; Ciociola, T.; De Simone, T.; Conti, S.; Magliani, W.. - In: TOXINS. - ISSN 2072-6651. - 13:9(2021), p. 655.655. [10.3390/toxins13090655]

Wickerhamomyces yeast killer toxins’ medical applications

Giovati L.
Conceptualization
;
Ciociola T.
Writing – Original Draft Preparation
;
De Simone T.
Writing – Original Draft Preparation
;
Conti S.
Writing – Review & Editing
;
Magliani W.
Conceptualization
2021-01-01

Abstract

Possible implications and applications of the yeast killer phenomenon in the fight against infectious diseases are reviewed, with particular reference to some wide-spectrum killer toxins (KTs) produced by Wickerhamomyces anomalus and other related species. A perspective on the applications of these KTs in the medical field is provided considering (1) a direct use of killer strains, in particular in the symbiotic control of arthropod-borne diseases; (2) a direct use of KTs as experimental therapeutic agents; (3) the production, through the idiotypic network, of immunological derivatives of KTs and their use as potential anti-infective therapeutics. Studies on immunological derivatives of KTs in the context of vaccine development are also described.
2021
Wickerhamomyces yeast killer toxins’ medical applications / Giovati, L.; Ciociola, T.; De Simone, T.; Conti, S.; Magliani, W.. - In: TOXINS. - ISSN 2072-6651. - 13:9(2021), p. 655.655. [10.3390/toxins13090655]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2898303
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact